Diagnostic Performance of Procalcitonin and C-Reactive Protein in Pediatric Acute Pyelonephritis: A Hospitalbased Study
Journal of Pediatric Nephrology,
Vol. 10 No. 2 (2022),
1 October 2022
,
Page 83-90
https://doi.org/10.22037/jpn.v10i2.35634
Abstract
Background and Aim: Urinary Tract Infection (UTI) is a common bacterial infection in
children causing permanent renal damage. Differentiation between Acute Pyelonephritis
(APN) and lower UTI is vital due to the involvement of renal parenchyma in APN.
This study aimed to assess the efficiency of Procalcitonin (PCT) with C-Reactive
Protein (CRP) to predict APN in children with UTI in a tertiary care hospital.
Methods: This analytical cross-sectional study was conducted in a tertiary care hospital
between March 2013 and July 2014. Children aged 1 month to 16 years with febrile UTI
were included in the study Sensitivity, specificity,
positive predictive value, negative predictive value, and receiver operating characteristic
(ROC) curve were used to assess quantitative variables for diagnosing APN.
Results: The Mean±SD age values in the APN group were 73.11±52.29 months, while
it was 76.25±47.23 months in the lower UTI group. The Area Under the Curve
(AUC) for fever, White Blood Cell (WBC), CRP, and PCT of the respondent showed
that CRP was at the cut-off point of 5.0 mg/L, resulting in a sensitivity of 82.4% and a
specificity of 80.0%, respectively. PCT was at the cut-off point of 1300 pg/mL, resulting
in a sensitivity of 76.5% and a specificity of 100.0%, respectively. By comparing the
Receiver Operating Characteristic (ROC) curve, PCT had a significantly higher Area
Under the Curve (AUC) than CRP for differentiating APN and lower UTI.
Conclusion: Serum CRP and PCT are good markers for diagnosing APN in febrile UTI
in children. However, the study showed that PCT is a better marker to differentiate APN
and lower UTI compare to CRP.
- Urinary Tract Infection (UTI)
- procalcitonin (PCT)
- C-reactive protein (CRP)
How to Cite
References
2. Sheu JN, Chang HM, Chen SM, Hung TW, Lue KH. The role of Procalcitonin for acute pyelonephritis and subsequent renal scarring in infants and young children. Pediatric Urology 2011;186:2002-8.
3. Hiraoka M, Hashimoto G, Tshchida S, Tsukahara H, Oshhima T, Mayumi M. Early treatment of urinary infection prevents renal damage on cortical scintigraphy. Pediatr Nephrol 2003;18(2):115-18.
4. Ayazi P, Mahyar A, Hashemi HJ, Daneshi MM, Karimzadeh T, Salimi F. Comparison of procalcitonin and C-reactive protein tests in children with urinary tract infection. Iranian Journal of Pediatrics 2009;19(4):381-386.
5. Xu RY, Liu HW, Liu JL, Dong JH. Procalcitonin and C-reactive protein in urinary tract infection diagnosis. BMC Urology 2014;14:.45.
6. Garin EH, Olaverria F, Araya C, Broussain M, Berrara C, Young L. Diagnostic significance of clinical and laboratory findings to localize site of urinary tract infection. Pediatr Nephrol 2007; 22(7):1002-6.
7. Resswurm S, Wiederhold M, Oberhoffer M, Stonans I, Zipfel PF, Reinhart K. Molecular aspects and nautral sources of procalcitonin. Clin Chem Lab Med 1999; 37(8):789-97.
8. Wald E. Urinary tract infections in infants and children: a comprehensive overview. Pediatrics 2004;16:85-88.
9. Biggi A, Dardenelli L, Pomero G, Cussino P, Noello C, Sernia O. Acute renal cortical scintigraphy in children with first urinary tract infection. Pediatr Nephrol 2001;16(9):733-738.
10. Pecile P, Miorin E, Romanello C, Vidal E, Contardo M, Valent F. Age-related renal parenchymal lesions in children with first febrile urinary tract infections. Pediatrics 2009; 124(1):23.
11. Chen SM, Chang HM, Hung TW, Chao YH, Tasi JD, Lue KH. Diagnostic performance of procalcitonin for hospitalized children with acute pyelonephritis presenting to the pediatric emergency department. Emerg Med J, retrieved November 26, 2012, from doi: 10,1136/emermed-2011-200808.
12. Benador N, Siegrist CA, Genedrel D, Geneder C, Benador D, Assicot M. Procalcitonin is a marker of severity of renal lesions in pyelonephritis. Pediatrics 1998;102(6):1422-1425.
13. Simon L, Gauvin F, Amre DK, Louis PS, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clinical Infectious Disease 2004;39:206-17.
14. Prat C, Dominguez J, Rodrigo C, Gimenez M, Azura M, Jimenez O, et al. Elevated serum procalcitonin values correlate with renal scarring in children with urinary tract infection. Pediatr Infect Dis J 2003;22(5):438-442.
15. Nuyan N, Bircan ZE, Hasanoglu E, Bayhan H, Rota H. The importance of 99mTc DMSA scanning in the localization of childhood urinary tract infection. Int Urol Nephrol 1993;25(1):11-17.
16. Park JS, Byun YH, Lee JY, Lee JS, Ryu JM, Choi SJ. Clinical utility of procalcitonin in febrile infants younger than 3 months of age visiting a pediatric emergency room: a retrospective single-center study. BMC Pediatrics .2021. 21:109 https://doi.org/10.1186/s12887-021-02568-5
- Abstract Viewed: 160 times
- pdf Downloaded: 3098 times